Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: current status

被引：13

作者：

Bhayani, SB ^{[1
]}

Allaf, ME ^{[1
]}

Kavoussi, LR ^{[1
]}

机构：

[1] Johns Hopkins Med Inst, Baltimore, MD 21287 USA

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2004年 / 22卷 / 02期

关键词：

testis cancer; lymphadenectomy; retroperitoneal lymph node dissection; germ cell tumor;

D O I：

10.1016/j.urolonc.2004.01.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The purpose of the study was to update the current status of laparoscopic retroperitoneal lymph node dissection in the treatment of clinical Stage I nonseminomatous germ cell testicular cancer. A literature search was conducted to evaluate laparoscopic retroperitoneal lymph node dissection (RPLND) in comparison to other modalities of treatment. All treatment modalities are effective in treating clinical Stage I nonseminomatous germ cell tumors. Morbidity is the major issue that may guide treatment decisions. Laparoscopic RPLND, in its therapeutic form, may replicate open RPLND with a minimally invasive approach. Laparoscopic RPLND is an effective alternative to traditional treatment options. (C) 2004 Elsevier Inc. All rights reserved.

引用

页码：145 / 148

页数：4

共 50 条

[21] (P-RPLND) versus induction chemotherapy (IC) for the management of clinical stage (CS) IIA and IIB nonseminomatous germ cell testicular cancer (NSGCT)
Stephenson, AJ
Bosl, GJ
Bajorin, DF
Motzer, RJ
Stasi, JP
Carver, BS
Sheinfeld, J
JOURNAL OF UROLOGY, 2005, 173 (04): : 196 - 196
[22] Laparoscopic retroperitoneal lymph node dissection (L-RPLND) as therapeutic in stage I nonseminomatous germ cell testicular tumors: Findings from a referral center.
Nicolai, Nicola
Gasperoni, Francesca
Biasoni, Davide
Tarabelloni, Nicholas
Catanzaro, Mario
Stagni, Silvia
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
[23] Long-term results of laparoscopic retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testicular cancer
Neyer, Michael
Peschel, Reinhard
Akkad, Thomas
Springer-Stoehr, Brigette
Berger, Andreas
Bartsch, Georg
Steiner, Hannes
JOURNAL OF ENDOUROLOGY, 2007, 21 (02) : 180 - 183
[24] Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program
Tandstad, Torgrim
Dahl, Olav
Cohn-Cedermark, Gabriella
Cavallin-Stahl, Eva
Stierner, Ulrika
Solberg, Arne
Langberg, Carl
Bremnes, Roy M.
Laurell, Anna
Wijkstrom, Hans
Klepp, Olbjorn
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (13) : 2122 - 2128
[25] THE PROGNOSTIC RELEVANCE OF CONVENTIONAL PARAMETERS IN CLINICAL STAGE-I NONSEMINOMATOUS GERM-CELL TESTICULAR CANCER (NSGCT)
DERIESE, W
MESSEMER, J
SPRINGER, JP
FOSTER, RS
DERIESE, C
DONOHUE, JP
AKTUELLE UROLOGIE, 1994, 25 (02) : 84 - 87
[26] EXPECTANT THERAPY FOR CLINICAL STAGE-A NONSEMINOMATOUS GERM-CELL TESTICULAR CANCER - MAYBE
JEWETT, MAS
HERMAN, JG
STURGEON, JFG
COMISAROW, RH
ALISON, RE
GOSPODAROWICZ, MK
WORLD JOURNAL OF UROLOGY, 1984, 2 (01) : 57 - 58
[27] Chemotherapy for clinical stage I nonseminomatous germ cell tumours
Vaughn, David J.
BJU INTERNATIONAL, 2009, 104 (9B) : 1381 - 1386
[28] Management of clinical stage I nonseminomatous germ cell tumors
Isharwal, Sumit
Risk, Michael C.
EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (09) : 1021 - 1032
[29] A novel surveillance protocol for stage I nonseminomatous germ cell testicular tumours
Atsü, N
Eskiçorapçi, S
Üner, A
Ekici, S
Güngen, Y
Erkan, I
Uygur, MC
Özen, H
BJU INTERNATIONAL, 2003, 92 (01) : 32 - 35
[30] CYTOGENETIC ABNORMALITIES AND CLINICAL STAGE IN TESTICULAR NONSEMINOMATOUS GERM-CELL TUMORS
DEGRAAFF, WE
VANECHTENARENDS, J
OOSTERHUIS, JW
DEJONG, B
TEMEERMAN, GJ
WIERSEMABUIST, J
SLEIJFER, DT
KOOPS, HS
CANCER GENETICS AND CYTOGENETICS, 1993, 70 (01) : 12 - 16

← 1 2 3 4 5 →